CT-2106: Difference between revisions

From Medicine GPT
Jump to navigation Jump to search
(CSV import)
 
(CSV import)
Line 1: Line 1:
{{<span class="error">Expansion depth limit exceeded</span>|Term=CT-2106
{{Definitions
|Term=CT-2106
|Short definition=CT-2103 - A form of the cancer drug paclitaxel combined with a protein called polylumex that may have fewer side effects and work better than paclitaxel. It is being studied to treat breast cancer, ovarian cancer, lung cancer, and other types of cancer. 
|Short definition=CT-2103 - A form of the cancer drug paclitaxel combined with a protein called polylumex that may have fewer side effects and work better than paclitaxel. It is being studied to treat breast cancer, ovarian cancer, lung cancer, and other types of cancer. 
|Type=CT-2106 - A form of the cancer drug camptothecin that may have fewer side effects and work better than camptothecin. It is being studied in the treatment of cancer. It is a type of DNA topoisomerase inhibitor. Also called polyglutamate camptothecin {{<span class="error">Expansion depth limit exceeded</span>}} [[Category:Dictionary of medicine]]
|Type=Cancer terms
|Specialty=Oncology
|Language=English
|Source=NCI
}}
}}
CT-2106 - A form of the cancer drug camptothecin that may have fewer side effects and work better than camptothecin. It is being studied in the treatment of cancer. It is a type of DNA topoisomerase inhibitor. Also called polyglutamate camptothecin {{dictionary-stub}} [[Category:Dictionary of medicine]]

Revision as of 02:52, 8 January 2023

CT-2106
TermCT-2106
Short definitionCT-2103 - A form of the cancer drug paclitaxel combined with a protein called polylumex that may have fewer side effects and work better than paclitaxel. It is being studied to treat breast cancer, ovarian cancer, lung cancer, and other types of cancer. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


CT-2106 - A form of the cancer drug camptothecin that may have fewer side effects and work better than camptothecin. It is being studied in the treatment of cancer. It is a type of DNA topoisomerase inhibitor. Also called polyglutamate camptothecin

External links

Esculaap.svg

This MedicineGPT article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski